These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 155838)

  • 1. The effect of dopamine and noradrenaline blockade on amphetamine-induced behaviour in the marmoset.
    Scraggs PR; Ridley RM
    Psychopharmacology (Berl); 1979 Mar; 62(1):41-5. PubMed ID: 155838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural effects of amphetamine in a small primate: relative potencies of the d- and l-isomers.
    Scraggs PR; Ridley RM
    Psychopharmacology (Berl); 1978 Dec; 59(3):243-5. PubMed ID: 104327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of apomorphine and haloperidol: effects on locomotion and other behaviour in the marmoset.
    Scraggs PR; Baker HF; Ridley RM
    Psychopharmacology (Berl); 1979; 66(1):41-3. PubMed ID: 120540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat.
    Pijnenburg AJ; Honig WM; Van Rossum JM
    Psychopharmacologia; 1975; 41(2):87-95. PubMed ID: 1098086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the behavioural effects of amphetamine by a GABA agonist in a primate species.
    Ridley RM; Scraggs PR; Baker HF
    Psychopharmacology (Berl); 1979 Aug; 64(2):197-200. PubMed ID: 115041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural effects of chronic amphetamine and their reversal by haloperidol in the marmoset [proceedings].
    Baker HF; Ridley RM
    Br J Pharmacol; 1979 May; 66(1):146P-147P. PubMed ID: 110385
    [No Abstract]   [Full Text] [Related]  

  • 7. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1979 Jun; 64(1):45-54. PubMed ID: 113831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The time course of the behavioral effects of amphetamine and their reversal by haloperidol in a primate species.
    Ridley RM; Baker HF; Scraggs PR
    Biol Psychiatry; 1979 Oct; 14(5):753-65. PubMed ID: 115505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a noradrenergic mechanism in the grooming produced by (+)-amphetamine and 4, alpha-dimethyl-m-tyramine (H 77/77) in rats.
    Lassen JB
    Psychopharmacology (Berl); 1977 Oct; 54(2):153-7. PubMed ID: 144928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical effects of d-amphetamine on behavioral thermoregulation: possible mediation by brain dopamine.
    Yehuda S; Wurtman RJ
    J Pharmacol Exp Ther; 1974 Jul; 190(1):118-22. PubMed ID: 4367895
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes at cholecystokinin receptors induced by long-term treatment with diazepam and haloperidol.
    Vasar E; Soosaar A; Harro J; Lang A
    Eur Neuropsychopharmacol; 1992 Dec; 2(4):447-54. PubMed ID: 1490096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-sensitive alternation and collateral behaviour in a Y-maze: effects of d-amphetamine and haloperidol.
    Oades R; Taghzouti K; Simon H; Le Moal M
    Psychopharmacology (Berl); 1985; 85(1):123-8. PubMed ID: 3920694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time sampling observation procedure for studying drug effects: interaction between d-amphetamine and selective dopamine receptor antagonists in the rat.
    Petry N; Furmidge L; Tong ZY; Martin C; Clark D
    Pharmacol Biochem Behav; 1993 Jan; 44(1):167-80. PubMed ID: 8430120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperactivity induced by tetrahydroisoquinoline derivatives injected into the nucleus accumbens.
    Costall B; Naylor RJ; Pinder RM
    Eur J Pharmacol; 1976 Sep; 39(1):153-60. PubMed ID: 134899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
    Tschanz JT; Rebec GV
    Pharmacol Biochem Behav; 1988 Nov; 31(3):519-22. PubMed ID: 3251235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of (+)-amphetamine and apomorphine on visually determined behaviour in the marmoset [proceedings].
    Ridley RM
    Br J Pharmacol; 1978 Jun; 63(2):382P-383P. PubMed ID: 96900
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats.
    Rolinski Z; Scheel-Krüger J
    Acta Pharmacol Toxicol (Copenh); 1973; 33(5):385-99. PubMed ID: 4149038
    [No Abstract]   [Full Text] [Related]  

  • 18. Antagonism of cocaine, amphetamine, and methamphetamine toxicity.
    Derlet RW; Albertson TE; Rice P
    Pharmacol Biochem Behav; 1990 Aug; 36(4):745-9. PubMed ID: 2217500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific antagonism by dopamine inhibitors of items of amphetamine induced aggressive behaviour.
    Hasselager E; Rolinski Z; Randrup A
    Psychopharmacologia; 1972; 24(4):485-95. PubMed ID: 5064290
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of DA in the stimulant effect of DITA in mice; comparison with d-amphetamine.
    Abdallah AH; Roby DM; Boeckler WH; Riley CC
    Eur J Pharmacol; 1976 Jan; 35(1):29-34. PubMed ID: 1253826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.